Citation

De Fusco C, Schimpl M, Börjesson U, Cheung T, Collie I, Evans L, Narasimhan P, Stubbs C, Vazquez-Chantada M, Wagner DJ, Grondine M, Sanders MG, Tentarelli S, Underwood E, Argyrou A, Smith JM, Lynch JT, Chiarparin E, Robb G, Bagal SK, Scott JS.: Fragment-Based Design of a Potent MAT2a Inhibitor and <i>in Vivo</i> Evaluation in an MTAP Null Xenograft Model. J Med Chem, Volume 64 (10), 2021

Authors

Argyrou A, Bagal SK, Börjesson U, Cheung T, Chiarparin E, Collie I, De Fusco C, Evans L, Grondine M, Lynch JT, Narasimhan P, Robb G, Sanders MG, Schimpl M, Scott JS., Smith JM, Stubbs C, Tentarelli S, Underwood E, Vazquez-Chantada M, Wagner DJ

Journal

J Med Chem

Year

2021

DOI

10.1021/acs.jmedchem.1c00067

PubMed

33900758

Machine-readable

REST APIRDF